Captrust Financial Advisors Intercept Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $133 - $177	10 New	10 $0
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $185 - $253	-13 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$12.99 - $20.47 $1,974 - $3,111	-152 Reduced 92.12%	13 $0
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $14,393 - $22,809	-931 Reduced 84.95%	165 $3,000
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $17,996 - $35,145	931 Added 564.24%	1,096 $25,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $7,705 - $15,186	165 New	165 $8,000
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $16,060 - $34,748	-280 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $16,433 - $22,528	280 New	280 $19,000
Q4 2018 Feb 13, 2019	SELL	$85.79 - $126.46 $4,289 - $6,323	-50 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$88.49 - $127.55 $4,424 - $6,377	50 New	50 $6,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.